Additionally, MHR was positively correlated with tumor differentiation in CRC patients (P = 0.049); CEA and CA199 levels in CRC patients increased with increased stage, lymph node metastasis and tumor size ≥ 5 cm (all P < 0.05). The gene discussed is CEACAM5; the disease is metastatic malignant neoplasm in the lymph nodes.